The role of integrins in the trabecular meshwork

Journal of Ocular Pharmacology and Therapeutics

Volumn 30, Issue 2-3, 2014, Pages 110-120

  Gagen, Debjani ^a   Faralli, Jennifer A ^a   Filla, Mark S ^a   Peters, Donna M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GROWTH FACTOR; HETERODIMER; INTEGRIN; PROTEIN BINDING;

APOPTOSIS; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PHAGOCYTOSIS; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; CELL ADHESION; PHYSIOLOGY;

APOPTOSIS; CELL ADHESION; CYTOSKELETON; HUMANS; INTEGRINS; PROTEIN BINDING; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK;

EID: 84898722360     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0176     Document Type: Review

References (111)

1. Tervo, K., Paallysaho, T., Virtanen, I., and Tervo, T. Integrins in human anterior chamber angle. Graefes Arch. Clin. Exp. Ophthal. 233:291-295, 1995.
2. Zhou, L., Zhang, S.R., and Yue, B.Y. Adhesion of human trabecular meshwork cells to extracellular matrix proteins. Roles and distribution of integrin receptors. Invest. Ophthal. Vis. Sci. 37:104-113, 1996.
3. Zhou, L., Maruyama, I., Li, Y., Cheng, E.L., and Yue, B.Y. Expression of integrin receptors in the human trabecular meshwork. Curr. Eye Res. 19:395-402, 1999.
4. Humphries, J.D., Byron, A., and Humphries, M.J. Integrin ligands at a glance. J. Cell Sci. 119:3901-3903, 2006.
5. Kim, C., Ye, F., and Ginsberg, M.H. Regulation of integrin activation. Annu. Rev. Cell Dev. Biol. 27:321-345, 2011.
6. Giancotti, F.G., and Ruoslahti, E. Integrin signaling. Science. 285:1028-1032, 1999.
7. Stupack, D.G., Puente, X.S., Boutsaboualoy, S., Storgard, C.M., and Cheresh, D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol.155:4459-4470, 2001.
8. Zhao, H., Ross, F.P., and Teitelbaum, S.L. Unoccupied alpha( v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal. Mol. Endocrinol. 19:771-780, 2005.
9. Shattil, S.J., Kim, C., and Ginsberg, M.H. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 11:288-300, 2010.
10. Legate, K.R., and Fassler, R. Mechanisms that regulate adaptor binding to b-integrin cytoplasmic tails. J. Cell Sci. 122:187-198, 2009.
11. Filla, M., Schwinn, M.K., Nosie, A.K., Clark, R.W., and Peters, D.M. Dexamethasone-associated cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells involves b3 integrin signaling. Invest. Ophthal. Vis. Sci. 52:2952-2959, 2011.
12. Rose, A.Y. et al. Association for research in vision and ophthalmology. Invest. Ophthalmol. Vis. Sci. 2002, 43:E-Abstract 1045.
13. Dickerson Jr., J.E., Steely Jr., H.T., English-Wright, S.L., and Clark, A.F. The effect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells. Exp. Eye Res. 66:731-738, 1998.
14. Rozsa, F.W., Reed, D.M., Scott, K.M., et al. Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol. Vis. 12:125-141, 2006.
15. Clark, R., Nosie, A., Walker, T.M., et al. Comparative genomic and proteomic analysis of cytoskeletal changes in dexamethasone-treated trabecular meshwork cells. Mol. Cell Proteomics. 12:194-206, 2013.
16. Gagen, D., Filla, M., Clark, R., Litton, P., and Peters, D.M. Integrins modulate phagocytosis in human trabecular meshwork (TM) cells. Invest. Ophthal. Vis. Sci. 54:5000-5011, 2013.
17. Junglass, B., Yu, A.H.L., Welge-Lussen, U., Tamm, E., and Fuchshofer, R. Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells. Exp. Eye Res. 88:1065-1075, 2009.
18. Lai, C.-F., Feng, X., Nishimura, R., et al. Transforming Growth Factor-b up-regulates the b5 integrin subunit expression via Sp1 and Smad signaling. J. Biol. Chem. 275:36400-36406, 2000.
19. Pechkovsky, D.V., Scaffidi, A.K., Hackett, T.L., et al. Transforming growth factor beta1 induces alphavbeta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway. J. Biol. Chem. 283:12898-12908, 2008.
20. Roberts, C.J., Birkenmeier, T.M., McQuillan, J.J., Akiyama, S.K., Yamada, S.S., Chen, W T., Yamada, K.M., and McDonald, J.A. Transforming growth factor b stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts.. J. Biol. Chem. 263:4586-4592, 1988.
21. Heino, J., Ignotz, R.A., Hemler, M.E., Crouse, C., and Massagué, J. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J. Biol. Chem. 264:380-388, 1989.
22. Bollinger, K.E., Crabb, J.S., Yuan, X., et al. Quantitative proteomics: TGFb2 signaling in trabecular meshwork cells. Invest. Ophthal. Vis. Sci. 52:8287-8294, 2011.
23. Li, G., Luna, C., Qiu, J., Epstein, D.L., and Gonzalez, P. Targeting of integrin beta1 and kinesin 2 alpha by micro-RNA 183. J. Biol. Chem. 285:5461-5471, 2010.
24. Paylakhi, S.H., Moazzeni, H., Yazdani, S., et al. FOXC1 in human trabecular meshwork cells is involved in regulatory pathway that includes miR-204, MEIS2, and ITGb1. Exp. Eye Res. 111:112-121, 2013.
25. Tzima, E., Angel del Pozo, M., Shattil, S.J., Chien, S., and Schwartz, M.A. Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J. 20:4639-4647, 2001.
26. Alon, R., and Dustin, M.L. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity. 26:17-27, 2007.
27. Faralli, J.A., Gagen, D., Filla, M.S., Crotti, T.N., and Peters, D.M. Dexamethasone increases avb3 integrin expression and affinity through a calcineurin/NFAT pathway. Biochim. Biophys. Acta. 2013. DOI: 10.1016/j.bbamcr.2013.09.020.
28. Joe, M.K., Sohn, S., Kim, T.E., et al. Analysis of glucocorticoid-induced MYOC expression in human trabecular meshwork cells. Vis. Res. 51:1033-1038, 2011.
29. Shepard, A.R., Jacobson, N., Fingert, J.H., et al. Delayed secondary glucocorticoid responsiveness of MYCO in human trabecular meshwork cells. Invest. Ophthal. Vis. Sci. 42:3173-3181, 2001.
30. Filla,M., Woods, A., Kaufman, P.L., and Peters, D.M.P. b1 and b3 integrins cooperate to induce syndecan-4 containing crosslinked actin networks (CLANs) in human trabecular meshwork (HTM) cells Invest. Ophthal. Vis. Sci.; 47:1956-1967, 2006.
31. Clark, A.F., Wilson, K., McCartney, M.D., et al. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest. Ophthal. Vis. Sci. 35:281-294, 1994.
32. Clark, A.F., Brotchie, D., Read, A.T., et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil. Cytoskeleton. 60:83-95, 2005.
33. Fogerty, F.J., Akiyama, S.K., Yamada, K.M., and Mosher, D.F. Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (a5b1) antibodies. J Cell Biol. 111:699-708, 1990.
34. Li, S., Van Den Diepstraten, C., D'Souza, S.J., Chan, B.M.C., and Pickering, J.G. Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA and fibronectin polymerization. Am. J. Pathol. 163:1045-1056, 2003.
35. Singh, P., Carraher, C., and Schwarzbauer, J.E. Assembly of fibronectin extracellular matrix. Annu. Rev. Cell Dev. Biol. 26:397-419, 2010.
36. Dallas, S.L., Chen, Q., and Sivakumar, P. Dynamics of assembly and reorganization of extracellular matrix proteins. Curr. Top. Dev. Biol. 75:1-24, 2006.
37. Schlotzer-Schrehardt, U. Molecular pathology of pseudoexfoliation syndrome/glaucoma-New insights from LOX1 gene associations. Exp. Eye Res. 88:776-785, 2009.
38. Shi, F., and Sottile, J. Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J. Cell Sci. 121:2360-2371, 2008.
39. Shi, F., Harman, J., Fujiwara, K., and Sottile, J. Collagen I matrix turnover is regulated by fibronectin polymerization. Am. J. Physiol. Cell Physiol. 298:C1265-C1275, 2010.
40. Zhong, C., Chrzanowska Wodnicka,M., Brown, J., et al. Rhomediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 141:539-551, 1998.
41. Sechler, J.L., Cuminsky, A.M., Gazzola, D.M., and Scwarzbauer, J.E. A novel RGD-independant fibronectin assembly pathway initiated by alpha4beta1 integrin binding to the alternatively spliced V region. J. Cell Sci. 113(Pt 8):1491-1498, 2000.
42. Zhang, Z., Morla, A.O., Vuoori, K., et al. The avb1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin. J. Cell Biol. 122:235-242, 1993.
43. Wu, C., Hughes, P.E., Ginsberg, M.H., and McDonald, J.A. Identification of a new biological function for the integrin avb3: initiation of fibronectin matrix assembly. Cell Adhes. Commun. 4:149-158, 1996.
44. Olorundare, O.E., Peyruchaud, O., Albrecht, R.M., and Mosher, D.F. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophospahtidic and other agonists. Blood. 98:117-124, 2001.
45. Zhang, Q., Checovich, W.J., Peters, D.M., Albrecht, R.M., and Mosher, D.F. Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid. J. Cell Biol. 127: 1447-1459, 1994.
46. Zhang, Q., Peyruchaud, O., French, K.J., Magnusson, M.K., and Mosher, D.F. Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Blood. 93:2984-2990, 1999.
47. Halliday, N.L., and Tomasek, J.J. Mechanical properties of the extracellular matrix influence fibronectin fibril assembly in vitro. Exp. Cell Res. 217:109-117, 1995.
48. Carraher, C.L., and Schwarzbauer, J. Regulation of matrix assembly through rigidity-dependent fibronectin conformational changes. J. Biol. Chem. 288:14805-14814, 2013.
49. Last, J.A., Pan, T., Ding, Y., et al. Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest. Ophthal. Vis. Sci. 52:2147-2152, 2011.
50. Johnson, D.H., Richardson, T.M., and Epstein, E. Trabecular meshwork recovery after phagocytic challenge. Curr. Eye Res. 8:1121-1130, 1989.
51. Matsumoto, Y., and Johnson, D.H. Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ. Invest. Ophthal. Vis. Sci. 38:1902-1907, 1997.
52. Matsumoto, Y., and Johnson, D.H. Trabecular meshwork phagocytosis in glaucomatous eyes. Ophthalmologica. 211:147-152, 1997.
53. Rohen, J.W., and van der Zypen, E. The phagocytic activity of the trabecularmeshwork endothelium. An electronmicroscopic study of the vervet (Cercopithecus aethiops). Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 175:143-160, 1968.
54. Zhang, X., Ognibene, C.M., Clark, A.F., and Yorio, T. Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor b. Exp. Eye Res. 84:275-284, 2007.
55. Grierson, I., and Lee, W.R. Erythrocyte phagocytosis in the human trabecular meshwork. Br. J. Ophthalmol. 57:400-415, 1973.
56. Grierson, I., Day, J., Unger, W.G., and Ahmed, A. Phagocytosis of latex microspheres by bovine meshwork cells in culture. Graefes Arch. Clin. Exp. Ophthalmol. 224:536-544, 1986.
57. Porter, K.M., Epstein, D.L., and Liton, P.B. Up-regulated expression of extracellular matrix remodeling genes in phagocytically challenged trabecular meshwork cells. PLoS One. 7:e34792, 2012.
58. Finnemann, S.C. Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors. EMBO J. 22:4143-4154, 2003.
59. Finnemann, S.C., Bonilha, V.L., Marmorstein, A.D., and Rodriguez-Boulan, E. Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. Proc. Natl. Acad. Sci. USA. 94:12932-12937, 1997.
60. Finnemann, S.C., and Nandrot, E.F. MerTK activation during RPE phagocytosis in vivo requires alphaVbeta5 integrin. Adv. Exp. Med. Biol. 572:499-503, 2006.
61. Dupuy, A.G., and Caron, E. Integrin-dependent phagocytosis: spreading from microadhesion to new concepts. J. Cell Biol. 121:1773-1783, 2008.
62. Filla, M., Schwinn, M.K., Sheibani, N., Kaufman, P.L., and Peters, D.M. Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct b1 and b3 integrin pathways Invest. Ophthal. Vis. Sci. 50:5723-5731, 2009.
63. Ivaska, J., and Heino, J. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu. Rev. Cell Dev. Biol. 27:291-320, 2011.
64. Zhao, X., Ramsey, K.I., Stephan, D.A., and Russell, P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth-b. Invest. Ophthal. Vis. Sci. 45:4023-4034, 2004.
65. Flugel-Koch, C., Ohlmann, A., Fuchshofer, R., Welge-Lussen, U., and Tamm, E.R. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone. Exp. Eye Res. 79:649-663, 2004.
66. Fleenor, D.L., Shepard, A.R., Hellberg, P.E., et al. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest. Ophthal. Vis. Sci. 47:226-234, 2006.
67. Kang, M.H., Oh, D.J., Kang, J.H., and Rhee, D.J. Regulation of SPARC by transforming growth factor b2 in human trabecular meshwork. Invest. Ophthal. Vis. Sci. 54:2523-2532, 2013.
68. Wang, D., Sun, L., Zborowska, E., et al. Control of type II transforming growth factor-b receptor expression by integrin ligation. J. Biol. Chem. 274:12840-12847, 1999.
69. Reynolds, L.E., Conti, F.J., Lucas, M., et al. Accelerated reepithelialization in 3-integrin-deficient-mice is associated with enhanced TGF-1 signaling. Nat. Med. 11:167-174, 2005.
70. di Blasio, L., Droetto, S., Norman, J., Bussolino, F., and Primo, L. Protein kinase D1 regulates VEGF-A-induced avb3 integrin trafficking and endothelial cell migration. Traffic. 11:1107-1018, 2010.
71. Reynolds, A.R., Hart, I.R., Watson, A.R., et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat. Med. 15:392-400, 2009.
72. Streuli, C.H., and Akhtar, N. Signal co-operation between integrins andother receptor systems. Biochem. J. 418:491-506, 2009.
73. Alam, N., Goel, H.L., Zarif, M.J., et al. The integrin-growth factor receptor duet. J. Cell Physiol. 213:649-653, 2007.
74. Scaffidi, A.K., Petrovic, N., Moodley, Y.P., et al. avb3 integrin interacts with the transforming growth factor b (TGFb) type II receptor to potentiate the proliferative effects of TGFb1 in living human lung fibroblasts. J. Biol. Chem. 279:37726-37733, 2004.
75. Galliher, A.J., and Schiemann, W.P. b3 Integrin and Src facilitate transforming growth factor-b mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res. 8:R42, 2006.
76. Sieg, D.J., Hauck, C.R., Llic, D., et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2:249-256, 2000.
77. Carlson, T.R., Feng, Y., Maisonpierre, P.C., Mrksich, M., and Morla, A.O. Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276:26516-26525, 2001.
78. Munger, J.S., and Sheppard, D. Cross talk among TGF-b signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb. Perspect. Biol. 3:a005017, 2011.
79. Mattila, E., Pellinen, T., BNevo, J., et al. Negative regulation of EGFR signaling through integrin a1b1-mediated actiavtion of protein tyrosine phosphasts TCPTP. Nat. Cell Biol. 7:78-85, 2005.
80. Schwartz, M.A., and Assoian, R.K. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J. Cell Sci. 114:2553-2560, 2001.
81. Wang, L., Dong, Z., Zhang, Y., and Miao, J. The roles of integrin b4 in vascular endothelial cells. J. Cell Physiol. 227:474-478, 2012.
82. Burridge, K., and Chrzanowska-Wodnicka, M. Focal adhesions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 12:463-518, 1996.
83. Schoenwaelder, S.M., and Burridge, K. Bidirectional signaling between the cytoskeleton and integrins. Curr. Opin. Cell Biol. 11:274-286, 1999.
84. Arthur, W.T., Noren, N.K., and Burridge, K. Regulation of Rho family GTPases by cell-cell and cell-matrix adhesion. Biol. Res. 35:239-246, 2002.
85. Ridley, A.J. Rho GTPases and cell migration. J. Cell Sci. 114:2713-2722, 2001.
86. Tian, B., Geiger, B., Epstein, D.L., and Kaufman, P.L. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest. Ophthal. Vis. Sci. 41:619-623, 2000.
87. Rao, P.V., Peterson, Y.K., Inoue, T., and Casey, P.J. Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Invest. Ophthal. Vis. Sci. 49:2464-2471, 2008.
88. Liu, S., Rose, D.M., Han, J., and Ginsberg, M.H. a4 integrins in cardiovascular development and diseases. Trends Cardiovasc. Med. 10:253-257, 2000.
89. Gonzalez, J.M.J., Hu, Y., Gabelt, B., Kaufman, P.L., and Peters, D.M. Identification of the active site in the Heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments. Invest. Ophthal. Vis. Sci. 50:235-241, 2009.
90. Gonzalez, J.M.J., Peterson, J.A., Peters, J.M., Newman, J., and Peters, D.M. Effect of Heparin II domain of fibronectin on actin cytoskeleton and adherens junctions in human trabecular meshwork cultures. Invest. Ophthal. Vis. Sci. 47:2924-2931, 2006.
91. Schwinn, M.K., Gonzalez, J.M.J., Gabelt, B., et al. Heparin II domain of fibronectin mediates contractility through an a4b1 integrin co-signaling pathway. Exp. Eye Res. 316:1500-1512, 2010.
92. Santas, A.J., Bahler, C., Peterson, J.A., et al. Effect of Heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest. Ophthal. Vis. Sci. 44:4796-4801, 2003.
93. Clark, A.F., Miggans, S.T., Wilson, K., Browder, S., and McCartney, M.D. Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. J. Glaucoma. 4:183-188, 1995.
94. O'Reilly, S., Pollock, N., Currie, L., et al. Inducers of crosslinked actin networks in trabecular meshwork cells. Invest. Ophthal. Vis. Sci. 52:7316-7324, 2011.
95. Peterson, J.A., Sheibani, N., David, G., Garcia-Pardo, A., and Peters, D.M. Heparin II domain of fibronectin uses a4b1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4. J. Biol. Chem. 280:6915-6922, 2004.
96. Sharma, A., Askari, J.A., Humphries, M.J., Jones, E.Y., and Stuart, D.I. Crystal structure of a heparin-and integrinbinding segment of human fibronectin. EMBO J. 18:1468-1479, 1999.
97. Gonzalez, A.M., Bhattacharya, R., deHart, G.W., and Jones, J.C. Transdominant regulation of integrin function: mechanisms of crosstalk. Cell Signal. 22:578-583, 2010.
98. Retta, S.F., Cassara, G., D'Amato, M., et al., Cross talk betweem b1 and av integrins: b1 affects b3mRNA stability. Mol. Biol. Cell. 12:3126-3138, 2001.
99. Caswell, P.T., Vadrevu, S., and Norman, J.C. Integrins:masters and slaves of endocytic transport. Nat. Rev. Mol. Cell Biol. 10:843-853, 2009.
100. Bledzka, K., Smyth, S.S., and Plow, E.F. Integrin aIIbb3: From discovery to efficacious therapeutic target. Circ. Res. 112:1189-1200, 2013.
101. Mousa, S.A. av Vitronectin receptors in vascular-mediated disorders. Med. Res. Rev. 23:190-199, 2003.
102. Gutheil, J.C., Campbell, T.N., Pierce, P.R., et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin avb3. Clin. Cancer Res. 6:3056-3061, 2000.
103. Kummer, C., and Ginsberg, M.H. New approaches to blockade of a4-integrins, proven therapeutic targets in chronic inflammation. Biochem. Pharmacol. 72:1460-1468, 2006.
104. Alghisi, G.C., Ponsonnet, L., and Ruegg, C. The integrin antagonist cilengitide activates avb3, disrupts VE-cadherin localization at ell junctions and enhnaces permeability in endothelial cells. PLoS One. 4:e4449, 2009.
105. Marcinkiewicz, C., Weinreb, P.H., Calvete, J.J., et al. Obtustatin: a potent slecive inhibitor of a1b1 integrin in vitro and angiogenesis in vivo. Cancer Res. 63:2020-2023, 2003.
106. Overby, D., Gong, H., Qiu, G., Freddo, T., and Johnson, M.F. The mechanism of increasing outflow facility during washout in the bovine eye. Invest. Ophthal. Vis. Sci. 43:3455-3464, 2002.
107. Bahler, C.K., Hann, C.R., Fautsch, M.P., and Johnson, D.H. Pharmacologic Disruption of Schlemm's Canal Cells and Outflow Facility in Anterior Segments of Human Eyes Invest. Ophthal. Vis. Sci. 45:2246-2254, 2004.
108. Shimaoka, M., and Springer, T.A. Therapeutic antagonists and conformational regulation of integrin function. Nat. Rev. Drug Discov. 2:703-716, 2003.
109. Mogford, J.E., DAvis, G.E., Platts, S.H., and Meininger, G.A. Vascular smooth muscle avb3 integrin mediates arteriolar vasodilaton in response to RGD peptides. Circ. Res. 79:821-826, 1996.
110. Legler, D.F., Wiedle, G., Ross, F.P., and Imhof, B.A. Superactivation of integrin avb3 by low antagonist concentrations. J. Cell Sci. 114:1545-1553, 2001.
111. Kalishwaralal, K., BarathManiKanth, S., Pandian, S.R.K., Deepak, V., and Gurunathan, S. Silver nano-A trove for retinal therapies. J. Control Release. 145:76-90, 2010.